Single Ascending Oral Dose Phase 1 Study of ID110521156 in Healthy Adult Subjects

Clinical trial NCT06063291 · COMPLETED

Trial details

NCT number: NCT06063291
Sponsor: IlDong Pharmaceutical Co Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Adult Subjects

Start date: 2023-11-20
Primary completion: 2024-07-11
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.